| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 9 | -353,633 | 100% | $35.20 | -$12,446,759 |
| Net | -9 | -353,633 | -100% | -$12,446,759 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 10%+ Owner | $118,574,322 | -$946,250 | -0.79% | 13 Aug 2025 |
| Joseph Ciaffoni | President and CEO, Director | $14,992,018 | 12 Feb 2024 | ||
| Colleen Tupper | EVP & Chief Financial Officer | $5,228,256 | -$1,890,320 | -27% | 06 Nov 2025 |
| Scott Dreyer | EVP & Chief Commercial Officer | $5,041,984 | -$2,982,334 | -37% | 08 Dec 2025 |
| Alison B. Fleming | EVP & Chief Technical Officer | $4,638,457 | 10 Aug 2021 | ||
| Vikram Karnani | President and CEO, Director | $4,592,429 | 12 Nov 2025 | ||
| Richard Malamut | EVP and Chief Medical Officer | $4,204,935 | 10 Feb 2022 | ||
| GINO SANTINI | Director | $3,534,726 | -$201,018 | -5.4% | 15 Aug 2025 |
| Shirley R. Kuhlmann | EVP and General Counsel | $3,082,056 | -$3,335,262 | -52% | 04 Mar 2025 |
| John A. Fallon | Director | $3,051,603 | -$1,645,536 | -35% | 12 Nov 2025 |
| John G. Freund | Director | $2,986,960 | -$602,790 | -17% | 08 Aug 2025 |
| Thomas B. Smith | EVP and Chief Medical Officer | $2,699,830 | -$671,576 | -20% | 29 Aug 2025 |
| Rita J. Balice-Gordon | Director | $2,475,341 | -$171,673 | -6.5% | 05 Dec 2025 |
| David Dieter | EVP & General Counsel | $2,053,703 | 17 Mar 2025 | ||
| Gwen A. Melincoff | Director | $1,694,890 | 16 May 2024 | ||
| GAREN BOHLIN | Director | $1,667,296 | 15 May 2025 | ||
| Neil F. McFarlane | Director | $1,594,652 | 16 May 2024 | ||
| Michael Thomas Heffernan | Director | $1,536,011 | 10 Feb 2025 | ||
| Nancy Lurker | Director | $603,005 | 15 May 2025 | ||
| Carlos V. Paya | Director | $524,405 | 15 May 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|